Kimi Parent Moonshot Eyes HK IPO at $50 Billion Valuation; Keling AI Also Files

Many use Kimi to write reports and long-form content, but few know its parent company has not yet gone public. On October 6, Bloomberg brought this to light: Moonshot AI is reported to have completed its final private funding round at a valuation of approximately $50 billion—up roughly fivefold from about $10 billion in just one year. On the same day, Kuaishou placed its most valuable AI asset, Keling AI, on the path to an IPO. These are not isolated IPO stories, but signals that AI capitalization on the Hong Kong stock market is shifting from isolated cases to a batch phenomenon: the window is real, and the competition within it is real too.

According to Bloomberg, Moonshot AI has completed its final pre-IPO private funding round, with a valuation of approximately $50 billion. The company has begun preparing for investor outreach and is expected to initiate preliminary discussions as early as this month. Previously, it was reported that Moonshot AI had confidentially submitted its listing application to the Hong Kong Stock Exchange, with Bank of America serving as the overall coordinator and CICC, Deutsche Bank, and Goldman Sachs acting as joint sponsors. The report noted that discussions are still ongoing and the IPO timeline may change; Moonshot AI has not responded to requests for comment.

On the same day, Bloomberg reported that Keling AI is collaborating with CICC, Goldman Sachs, and UBS to prepare for a Hong Kong IPO, aiming to list as early as next year with plans to raise at least $1 billion; details may still change, and Goldman Sachs and UBS declined to comment. Separately, according to prior reporting by The Information, regulators have initiated data security investigations into DeepSeek and Moonshot AI—whether this impacts valuation or timelines, no public conclusions have been reached.

Two announcements were made on the same day—we believe this is unlikely to be coincidental: the current market’s capacity to absorb new listings in Hong Kong, the pathway under Chapter 18C, and the preferences of southbound capital together form a window that may not last indefinitely. For companies preparing to list, securing the first-mover advantage is not about time—it’s about pricing power.

First, look at this curve: According to publicly reported data, three consecutive funding rounds from January to February increased the valuation from $10 billion to $18 billion; after the Series D in May, it reached approximately $20 billion; a summer round brought it to about $31.5 billion (other reports suggest a subsequent round reached around $35 billion, reflecting slight discrepancies in reporting); the latest round valued the company at approximately $50 billion—roughly a fivefold increase in one year.

The growth story is driven by revenue growth rate, not revenue scale. According to Bloomberg, ARR increased from approximately $300 million in June to around $1 billion currently, with the company projecting it could reach $2 billion by December—note that this is the company’s own projection. In terms of business model, the consumer segment offers tiered subscriptions for Kimi, while the enterprise segment provides underlying technological capabilities to businesses. The agent product Kimi Work was launched in June, and the open-source model Kimi K3, released in July, reportedly performs similarly to leading models from OpenAI and Anthropic on certain evaluation metrics.

Our view is that buying at a ~50x static price-to-sales ratio is not buying the current Moonshot, but rather entering a bet on the speed of ARR realization. Let’s do two rough calculations: a $50 billion valuation against $1 billion ARR yields a static ~50x multiple; even if ARR doubles as expected to $2 billion, the forward price-to-sales ratio would still be 25x. For reference, in the secondary market: Zhipu, based on its intraday market cap of approximately HK$313.4 billion on October 6 and its H1 ARR of ~$1.8 billion, implies a static multiple of ~22x. The multiple assigned to Moonshot in the private market is more than double that of its publicly traded peers—this gap can only be bridged by two outcomes: either ARR continues to grow at a pace exceeding current levels, or the IPO valuation reverts toward secondary market benchmarks. The essence of IPO pricing discussions is this negotiation; if Moonshot delivers ~$2 billion in ARR by December, that will be the first milestone validating this bet.

KPMG’s Q3 review, released on October 6 (as reported by the media), showed that in the first three quarters, 116 new listings raised over HK$388 billion, more than double the amount from the same period last year and the highest on record for this period; active listing applications exceeded 600, significantly above historical norms; full-year fundraising could reach HK$500 billion, which, if achieved, would break the annual record of HK$427 billion set in 2010.

Two key trends warrant close attention: high-tech enterprises (AI, semiconductors, robotics) account for over half of total fundraising, and equity issuance proceeds in the third quarter reached a record high; 19 special-purpose technology companies listed under Chapter 18C during the period, raising HK$36.2 billion, compared to only eight such listings over the past three years. Our assessment of the Chapter 18C channel is that it has shifted from a backup route to the main pathway—and once the main pathway opens, scarcity begins to count down. The listing eligibility criteria under Chapter 18C primarily include market capitalization and R&D investment requirements, without mandating profitability, thereby providing a listing avenue for special-purpose technology companies still in their investment phase. However, the greater the throughput of this channel, the thinner the scarcity premium each individual listing can enjoy—companies filing this year benefit from an open window, while those filing next year may face a fully allocated investor base.

Keling AI, launched in 2024, specializes in generative AI video. According to Bloomberg, following OpenAI’s shutdown of Sora, Chinese providers like Keling are vying to capture the market space it left behind; in July, the company completed a $2.8 billion funding round with a pre-money valuation of approximately $15 billion, with investors including Alibaba, Tencent, and Baidu. In late August, according to a Kuaishou announcement and related reports, the company secured an additional capital injection, exhausting its full independent fundraising target for the year.

Including Keling’s IPO in the competitive landscape, our interpretation is that this is a resupply in an arms race, not merely a shareholder exit. ByteDance’s Seedance, Shengshu Technology (according to Bloomberg, also planning a Hong Kong listing), and PixVerse (Aishi Technology, same as above) are all betting on the same track; the computational and data costs for video generation are extremely high, and the decisive factor in this race is likely not model rankings but cash flow endurance—whoever runs out of capital first will fall behind. It remains unknown how much of the void left by Sora’s exit can be filled or how long it can last; but the very length of the list of competitors serves as a signal: in this space, money is being burned faster than it’s being made.

The parent company’s stock price is another variable worth careful consideration. According to Bloomberg and confirmed by market data, Kuaishou’s stock has declined by more than 50% year-to-date (closing at HK$66.25 on the first trading day of 2026 and HK$30.18 on October 6). This double-edged sword cuts both ways: a weak parent company may suppress Ling’s valuation expectations; but conversely, separating AI assets from Kuaishou’s “content platform valuation” offers the market its first opportunity to price AI video services independently—whether this separation results in a premium or discount will be answered by the offering price. We tend to believe that this latter factor may also be one of the reasons Kuaishou is considering the spin-off.

Southbound funds are a key variable in driving demand. According to Wind data, Southbound funds have recorded a net inflow of HK$428.203 billion year-to-date (as of September 28), with a total holding market value of approximately HK$6.02 trillion (as of September 29). Among the top three-month net buyers, AI-related stocks lead the way—Zhipu at HK$40.021 billion, followed by MINIMAX-W at HK$11.411 billion. Based on this structure, if new listings such as Moonshot AI and Keling AI are listed and included in the Stock Connect program, their marginal buyers will likely come from this same pool of capital. Their post-listing performance will, in turn, shape Southbound funds’ overall sentiment toward the large model asset class—the performance of these first entrants will set the pricing environment for future listings.

The scarcity premium has an expiration date—that’s the answer to “why now.” After Zhipu and MINIMAX-W listed, they received continuous inflows from southern capital, primarily because there are so few large model stocks available through the Stock Connect program; according to KPMG’s metrics, just in the first three quarters, 19 companies listed under Rule 18C, with over 600 applications still queued. When “scarcity” turns into “bulk,” early entrants capture pricing power, while later entrants inherit the tail end of allocation demand. For companies preparing for IPOs, the pricing power during the window is more valuable than the window itself—this is our core understanding of the current surge in filings.

• Filing and hearing updates: The official application version on HKEXnews, particularly regarding the disclosure methodology for ARR composition, subscription, and B2B revenue breakdown;
• Feedback from initial investor meetings: The preliminary discussions, potentially launching as early as this month, provide the first-hand insight into how secondary buyers view a 50x static price-to-sales ratio;
• Can December ARR deliver the expected $2 billion? This is the key data point that determines whether the valuation story holds together.
• Kuaishou's stock price and market conditions: The parent company's performance, interest rate environment, and overall demand for new listings all influence the offering valuation.

Here are three key conclusions summarizing our assessment. First, Moonshot’s approximately 50x static price-to-sales ratio versus Zhipu’s 22x reflects a chasm of growth expectations between private and public markets—December’s ARR data will be a critical indicator: if achieved, it would provide some support for current valuations; if missed, it could increase the likelihood of market reevaluation. Second, the 18C channel transitioning from a backup to the main gate signals that scarcity is now counting down—this wave of密集 filings is fundamentally about securing pricing power, not just joining the crowd. Third, Keling AI’s IPO is an effort to replenish ammunition in the AI video arms race; the decisive factor lies in cash flow sustainability, not ranking positions—Kuaishou’s weak stock performance may both suppress valuation and serve as a catalyst for spin-off. These conclusions are based on currently available public information and are subject to change if conditions evolve.

Bloomberg (October 6, 2026), KPMG Q3 2026 Review, Wind, exchange market data, and public reports.

• Dark Side of the Moon: Estimated valuation of approximately $50 billion; planning to go public in Q1 2027 and raise up to $5 billion; ARR projected to grow from $3 billion to $10 billion to $20 billion; valuation projected at $10 billion → $18 billion → $20 billion → $31.5 billion (with an alternative estimate of $35 billion). The company has not officially disclosed this information.
• Moon Dark Side has appointed Merrill Lynch, CICC, Deutsche Bank, and Goldman Sachs as sponsors; submitted confidentially.
• Keling AI: Underwritten by CICC, Goldman Sachs, and UBS; planning to raise at least $1 billion; raised $2.8 billion in July with a pre-money valuation of approximately $15 billion. Kuaishou’s official announcement indicates additional financing commitments of approximately RMB 3 billion, among other differences.
• Hong Kong IPOs: 116 listings, over HK$388 billion, 600+ applications; 18C: 19 listings / HK$36.2 billion; technology sector accounts for over half; 2010 record: HK$427 billion.
• Southbound funds: cumulative net inflow of HK$428.203 billion, holdings of approximately HK$6.02 trillion; Zhipu HK$40.021 billion, MINIMAX-W HK$11.411 billion. As of 9/28–29.
• Kuaishou: Closed at HK$66.25 on the first trading day of 2026, and at HK$30.18 on 10/6 (approx. -54%).
• Price-to-Sales Ratio: Moonshot is approximately 50x on a static basis; Zhipu is approximately 22x (as of October 6, intraday market cap was approximately HK$313.4 billion, with H1 ARR of approximately $1.8 billion, calculated roughly). This calculation is approximate, using an exchange rate of approximately HK$7.78 per USD, for reference only and does not constitute a valuation judgment.

Note: Information regarding Moonshot AI and Keling AI has not been officially disclosed by the company; refer to media reports for accuracy. There are discrepancies between Keling AI’s announcements and the company’s official statements, which have been noted in the text.

Disclaimer:

The content of this article is provided solely for general information and market commentary purposes, based on publicly available data as of the time mentioned herein. Market data, expectations, and probabilities referenced herein may change due to market conditions. Opinions and investment strategies cited from third-party institutions, analysts, or other individuals reflect only their views at a specific point in time and do not represent the views or recommendations of BIT. This article does not constitute investment advice, investment research, an offer, solicitation, or recommendation for any securities, investment products, or trading strategies, and should not be used as the basis for any investment decision. Financial markets involve risk; security prices and market performance may fluctuate, and historical performance or past market trends do not indicate or guarantee future results. Investors should independently assess relevant risks based on their own circumstances and seek professional advice when necessary.